An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance

Mullerian Inhibiting Substance (MIS) has been shown to inhibit ovarian cancer cells both in-vitro and in-vivo. Furthermore, recent evidence suggests that MIS may effectively target a putative ovarian cancer progenitor cell population enriched by a panel of CD44+, CD24+, Ep-CAM+, and E-cadherin-cell...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pépin, D., Hoang, M., Nicolaou, F., Hendren, K., Benedict, L.A., Al-Moujahed, A., Sosulski, A., Marmalidou, A., Vavvas, D., Donahoe, P.K.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3980489/
https://ncbi.nlm.nih.gov/pubmed/24729676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1142/S2339547813500076
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items